OleanderPhoenix Biotechnology executes a sixth amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center. Posted on June 2011June 2022 by Carlos Torres 06 Jun Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center. Phoenix executes a Sponsored Research Agreement with Duke University for in vivo research in animal models to study prevention of ischemic stroke using PBI-05204.
